GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, as Britain's biggest drugmaker prepares to split its business into two.
Reuters: Business News, Reuters: Business
Mon, 01/21/2019 - 1:16am
GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, as Britain's biggest drugmaker prepares to split its business into two.